Adrian Rabin
Lawyers
Filters
Newfold Digital Holdings Group $515 million senior secured notes offering
The high-yield notes are due 2028
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Korro Bio $117 million private placement
The financing is expected to close immediately prior to the completion of Korro Bio’s merger with Frequency Therapeutics
Oculis Holding $40.25 million debut equity offering
The shares are listed on the Nasdaq Global Market
Seagate HDD Cayman $1 billion senior notes offering
The notes are due 2029 and 2031
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Gamida Cell $23 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market
Medtronic Global Holdings $2 billion notes offering
The investment-grade offering comprises two tranches of notes